Proteomics Labs Quantum-Si's benchtop single-molecule proteomics platform addresses core needs of academic and industry labs by enabling real-time, high-resolution protein analysis with simpler workflows. This creates a clear path to core facilities, early-stage biotechs, and contract research organizations seeking to modernize proteomics capabilities and reduce multistep workflows. Potential upsell opportunities include instrument sales, maintenance contracts, and consumables bundled with training and onboarding support.

Cloud Analytics Leverage the existing cloud-friendly tech stack to offer a data management and analytics layer that integrates with AWS and collaborative tools. This opens cross-sell opportunities for scalable data storage, analytics pipelines, dashboards, and secure shared access, creating a recurring revenue stream alongside hardware sales.

Expansion Opportunities Given a mid-size profile and market momentum in proteomics, target expansion into university core facilities, pharma R&D centers, and CROs in biotech hubs. Propose geographic expansion with localized service, training, and onsite demonstrations, and bundle with ongoing maintenance and consumables to drive repeat placements as labs scale their proteomics programs.

Competitive Edge Quantum-Si's approach enables real-time functional protein insights with high resolution on a benchtop platform, offering a differentiator against larger incumbents and multi-step workflows. Highlight ROI, faster results, and simpler workflows in sales messages, and tailor outreach to labs currently using traditional proteomics methods with demonstrations and case studies to accelerate conversions.

Market Signals Funding and potential investor interest, along with the company's public-market presence, signals buyer readiness and credibility for proteomics technologies. Use this narrative to support value-based selling, emphasizing accelerated discovery timelines, reduced complexity, and long-term total cost of ownership. Align outreach with typical R&D budgeting cycles and leverage testimonials and investor context in outreach materials.